Skip Navigation LinksHome > February 2012 - Volume 129 - Issue 2 > Disclosures and Registration: Lost in Translation?
Plastic & Reconstructive Surgery:
doi: 10.1097/PRS.0b013e31823aef69
Letters

Disclosures and Registration: Lost in Translation?

Freshwater, M. Felix M.D.

Free Access
Article Outline
Collapse Box

Author Information

University of Miami School of Medicine, 9100 South Dadeland Boulevard, Suite 502, Miami, Fla. 33156-7815

Back to Top | Article Outline

Sir:

I was intrigued by the article published ahead of print entitled “The Ideal Split-Thickness Skin Graft Donor-Site Dressing: A Clinical Comparative Trial of a Modified Polyurethane Dressing and Aquacel.”

Figure. No caption a...
Figure. No caption a...
Image Tools

The Journal has abided by the Declaration of Helsinki since 2007 by only accepting for peer review prospective clinical trials that have been registered.2 Article 19 of the Declaration of Helsinki clearly states: “Every clinical trial must be registered in a publicly accessible database before recruitment of the first subject [italics added].”3 This article does not state in which publicly accessible database the trial was registered. When I searched the World Health Organization database of clinical trial registries that includes not only clinicaltrial.gov but also the German Clinical Trials Register, the only trial that I was able to find matching this article was clinical trials.gov NCT01055925 that was not registered until January 25, 2010.4 This article states on page 24 that patient enrollment for this study commenced “in full accordance with the Helsinki declaration” in June of 2008. What happened? Is there some other publicly accessible registry not listed with the World Health Organization in which this trial was registered? Is the World Health Organization database incomplete? Did the quality control process of the Journal fail and an article that violated the Declaration of Helsinki and the Journal's own ethical standards somehow get peer-reviewed and accepted for publication? Is there some other explanation for why the only registry number that I could find for this trial was for a trial that had been registered more than 1 year after this trial began and 6 months after it ended?

M. Felix Freshwater, M.D.

University of Miami School of Medicine, 9100 South Dadeland Boulevard, Suite 502, Miami, Fla. 33156-7815

Back to Top | Article Outline

REFERENCES

1. Dornseifer U, Lonic D, Gerstung TI, et al.. The ideal split-thickness skin graft donor-site dressing: A clinical comparative trial of a modified polyurethane dressing and Aquacel. Plast Reconstr Surg. 2011;128:918–924.
2. Rohrich RJ, Longaker MT. Registering clinical trials in Plastic and Reconstructive Surgery. Plast Reconstr Surg. 2007;119:1097–1099.

3. World Medical Association. WMA Declaration of Helsinki: Ethical principles for medical research involving human subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/. Accessed July 24, 2011.

4. ClinicalTrials.gov Clinical comparative trial of a modified polyurethane dressing and Aquacel. Available at: http://clinicaltrials.gov/ct2/show/record/NCT01055925?term=NCT01055925&rank=1. Accessed July 24, 2011.

Back to Top | Article Outline
GUIDELINES

Letters to the Editor, discussing material recently published in the Journal, are welcome. They will have the best chance of acceptance if they are received within 8 weeks of an article's publication. Letters to the Editor may be published with a response from the authors of the article being discussed. Discussions beyond the initial letter and response will not be published. Letters submitted pertaining to published Discussions of articles will not be printed. Letters to the Editor are not usually peer reviewed, but the Journal may invite replies from the authors of the original publication. All Letters are published at the discretion of the Editor.

Letters submitted should pose a specific question that clarifies a point that either was not made in the article or was unclear, and therefore a response from the corresponding author of the article is requested.

Authors will be listed in the order in which they appear in the submission. Letters should be submitted electronically via PRS' enkwell, at www.editorialmanager.com/prs/.

We reserve the right to edit Letters to meet requirements of space and format. Any financial interests relevant to the content of the correspondence must be disclosed. Submission of a Letter constitutes permission for the American Society of Plastic Surgeons and its licensees and asignees to publish it in the Journal and in any other form or medium.

The views, opinions, and conclusions expressed in the Letters to the Editor represent the personal opinions of the individual writers and not those of the publisher, the Editorial Board, or the sponsors of the Journal. Any stated views, opinions, and conclusions do not reflect the policy of any of the sponsoring organizations or of the institutions with which the writer is affiliated, and the publisher, the Editorial Board, and the sponsoring organizations assume no responsibility for the content of such correspondence.

The Journal requests that individuals submit no more than five (5) letters to Plastic and Reconstructive Surgery in a calendar year.

©2012American Society of Plastic Surgeons

Login

Article Tools

Images

Share